🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mookho Malahleha

University of Cape Town

ORCID: 0000-0003-1879-8471

Also affiliated with Synergy Health

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9
Top 100%
0DataRank
Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Papers

Driven by 11 papers — median percentile 0. Top paper: “Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant”.

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine(2021)10.1056/nejmoa2102214
N/A
13.3DataRank · unranked
1321 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +46 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x
N/A
1.3DataRank · unranked
40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038
N/A
1.2DataRank · unranked
48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260
N/A
1.1DataRank · unranked
50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

medRxiv(2021)10.1101/2021.02.10.21251247
N/A
0.722DataRank · unranked
122 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +48 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320
N/A
0.425DataRank · unranked
16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

AIDS and Behavior(2023)10.1007/s10461-023-04025-z
N/A
0.208DataRank · unranked
3 citations

Fatima Laher, Athmanundh Dilraj, Philip Smith, Glenda Gray, Doug Grove +16 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319
N/A
0.108DataRank · unranked
1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9
Top 100%
0DataRank
Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials

UNC Libraries(2020)10.17615/zte5-vz84
N/A
0DataRank · unranked
0 citations

Johan Lombaard, Ansley Lemons, Mookho Malahleha, Douglas Taylor, Kawango Agot +6 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4
N/A
0DataRank · unranked
1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more